<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examined the effect of prolonged postischemic <z:chebi fb="2" ids="5615">halothane</z:chebi> administration on outcome from transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Conscious normothermic rats were subjected to 75 minutes of filament middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Animals were then divided into two groups </plain></SENT>
<SENT sid="3" pm="."><plain>The Awake group (n = 15) remained awake following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="2" ids="5615">Halothane</z:chebi> group (n = 15) received 1.3-1.4% <z:chebi fb="2" ids="5615">halothane</z:chebi> for 5 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of recirculation </plain></SENT>
<SENT sid="5" pm="."><plain>In both groups, brain temperature was maintained at 37.5 degrees C during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and the first 22 hours of recovery </plain></SENT>
<SENT sid="6" pm="."><plain>Seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, the severity of <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> and cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size were examined </plain></SENT>
<SENT sid="7" pm="."><plain>Neurologic scores did not differ between groups (Awake = 1+/-2.75; <z:chebi fb="2" ids="5615">Halothane</z:chebi> = 2+/-2; p = 0.772, median +/- interquartile range) </plain></SENT>
<SENT sid="8" pm="."><plain>Neurologic scores and total <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were correlated (R = 0.653; p = 0.0004) </plain></SENT>
<SENT sid="9" pm="."><plain>Cortical (Awake = 76+/-57 mm3; <z:chebi fb="2" ids="5615">Halothane</z:chebi> = 90+/-57 mm3; p = 0.494, mean +/- standard deviation), subcortical (Awake = 71+/-33 mm3; <z:chebi fb="2" ids="5615">Halothane</z:chebi> = 80+/-35 mm3; p = 0.472), and total (Awake = 147+/-88 mm3; <z:chebi fb="2" ids="5615">Halothane</z:chebi> = 171+/-91 mm3; p = 0.477) <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were not significantly different between groups </plain></SENT>
<SENT sid="10" pm="."><plain>The data indicate that postischemic <z:chebi fb="2" ids="5615">halothane</z:chebi> administration offers no benefit in ameliorating damage from focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>This suggests that the neuroprotective effect of <z:chebi fb="2" ids="5615">halothane</z:chebi> observed in other studies is consistent with influences on intra-ischemic pathophysiology only </plain></SENT>
</text></document>